Australia's most trusted
source of pharma news
Wednesday, 22 April 2026
Wednesday, 22 April 2026
Subscribe
Login
J&J chases record-breaking sales
Johnson & Johnson believes it will hit a record-breaking US$100 billion (AU$139 billion) in revenue this year. Find out how... and why not all analysts are convinced.
Oncolytic immunotherapy cleared
CRO wins the go-ahead to conduct a clinical trial in Australia for Akamis Bio's lead drug candidate in rectal cancer
TODAY
Final contender in MA Board race
Voting is now open to fill four vacancies on the Medicines Australia Board with an official count of 10 leaders in the running
TODAY
Meet the most profitable pharma
The top 13 most profitable pharmas named with one company, which had an 83 per cent gross margin, branded the standout
21 April
Best drug name of 2026 goes to...
Pharma industry professionals have decided this year's best drug name in a nail-biting final championship round
21 April
Jobs go in company streamlining
This company is the latest to streamline its operations with an undisclosed number of job losses
20 April
Drugs jostle for May PBS listing
After two big months for PBS listings, May is shaping up to be much quieter with only seven drugs in the final stage before listing
20 April
Latest Jobs
Trade Marketing ManagerTerritory Manager - SurgicalSenior Product ManagerAssistant AccoutantAssociate Marketing Manager - OTCInventory Team SupervisorSenior Medical Science LiaisonPharmaceutical Sales Representative31 more...
Pharma in Focus Jobs
Marketing & Communications (6)
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
- Senior Medical Communications Specialist - Sydney
Sales & Customer Relations (15)
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Specialist - Frenchs Forest
- Customer Service Representative - East Ryde
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - St Leonards
- Hospital Specialist Representative - Melbourne
- Commercial Analytics & SFE Specialist - Sydney
- Pharmaceutical Sales Representative - Sunshine Coast
- Customer Service Representative - Canning Vale
- Account Manager - Melbourne
- Accountant - Macquarie Park
- Customer Service Representative - Belrose
Clinical & Medical, R&D (9)
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Clinical Trials Investigator - Melbourne
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Medical Lead - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
- Senior Medical Communications Specialist - Sydney
- Warehouse & Medical Kit Assistant - Blacktown
Regulatory, Pharmacovigilance & QA (3)
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Medical Information Associate - Sydney
Executive Roles (1)
Other (9)
- Assistant Accoutant - Lane Cove West
- Inventory Team Supervisor - Melbourne
- Inventory Analyst - Sydney
- Warehouse Operator - Melbourne
- Inventory Analyst - Sydney
- Forklift Driver & Warehouse Assistant - Lane Cove
- Commercial Finance Analyst - Belrose
- Senior HR Business Partner - Melbourne
- Senior HRBP - Melbourne
Another ex-Govt staffer joins MA
Former Chief of Staff to a Cabinet Minister and one-time newsman joins Medicines Australia, to steer Public Affairs and Govt Relations
TODAY
From napkin to buyout in 10 years
An Australian pharma consulting firm with almost 500 market access projects under its belt now has international backing
TODAY
Lung cancer drug wins wider label
Expanded approval for use as a combination therapy under the FDA's Project Orbis but it's already been knocked back by the PBAC
21 April
PBS rules preventing best practice
PBAC-imposed restrictions on PBS-listed drugs are preventing clinicians from prescribing the best treatment for their patients
21 April
Gilead builds a new revenue play
With half its revenue coming from a single product, this company is spending big to diversify its earnings
21 April
Big win for 'high-potential' biotechs
Biointelect and venture-capital-as-a-service firm join forces to advance companies through the critical clinical development
20 April
GSK notches another RSV first
Company racks up its third win in this highly competitive space with its RSV vaccine the first to be added to the NIP for older Aussies
20 April
Two new drugs, first biosim ticked
New antibody-drug conjugate and a new antidote approved by the TGA alongside the first biosim of a Novartis cancer drug
20 April Approvals Action
Leaders pitch for MA Board role
Nine leaders are hoping to join the Medicines Australia Board with nominees pitching their case to fill four vacancies
17 April
Bosses crack the $40M Club
A handful of pharma company leaders have cracked a new milestone with compensation packages north of AU$40M
17 April
No TGA action after patient deaths
ICYMI: Despite 8 overseas deaths and action from the FDA, the TGA is taking a routine approach plus the other popular stories this week
17 April Your Week in 5 Minutes
New hurdle for Novartis therapy
Telix is suing to invalidate the patent protecting Pluvicto to open the door to launching its competitor treatment
17 April
PBS listing delivers for rare cancer
The funding of a second-generation drug has given patients with this rare form of lung cancer another option
17 April
Hyped drug doubles sales forecast
This drug, recently considered by the PBAC, is living up to the hype overseas, with the company doubling its peak sales projections
16 April